Equities

STRATA Skin Sciences Inc

STRATA Skin Sciences Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.411
  • Today's Change-0.019 / -4.44%
  • Shares traded4.97k
  • 1 Year change-61.94%
  • Beta1.5512
Data delayed at least 15 minutes, as of Apr 30 2024 16:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

  • Revenue in USD (TTM)33.36m
  • Net income in USD-10.83m
  • Incorporated1997
  • Employees99.00
  • Location
    STRATA Skin Sciences Inc5 Walnut Grove Dr Ste 140HORSHAM 19044-2252United StatesUSA
  • Phone+1 (215) 619-3200
  • Fax+1 (215) 619-3209
  • Websitehttp://www.strataskinsciences.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nexalin Technology Inc110.75k-4.65m11.53m6.00--3.59--104.08-0.6303-0.63030.0150.43120.020.165315.5418,458.33-84.03---106.99--76.81---4,197.48--7.70--0.00---91.62---173.80------
ALR Technologies Inc9.49k-8.00m12.00m6.00------1,264.57-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
Citrine Global Corp0.00-2.38m12.07m18.00---------0.0025-0.00250.00-0.00280.00----0.00-173.12-298.98---964.26-------4,814.84---5.41--------41.43---5.44--
Biotricity Inc11.63m-15.39m12.19m55.00------1.05-1.75-1.751.32-2.841.922.016.55211,408.70-240.40-303.46----65.5253.00-125.43-368.780.1012-0.5855----26.00--35.36------
Bionoid Pharma Inc0.001.35m13.50m13.000.2204--9.98--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
PetVivo Holdings Inc1.05m-10.63m13.75m25.00--13.67--13.15-0.8694-0.86940.08420.060.33751.212.0441,841.60-343.12-209.90-715.73-504.6451.4120.27-1,016.55-2,297.210.6169-2,268.840.1392--693.46260.32-73.83--51.73--
BioSig Technologies Inc18.00k-29.05m15.01m4.00------833.64-4.08-4.080.0025-0.32220.00610.001.094,500.00-971.23-269.73---363.1172.22---159,388.90-24,485.730.1152-------93.71---6.52---9.58--
STRATA Skin Sciences Inc33.36m-10.83m15.08m99.00--1.19--0.4521-0.3101-0.31010.95530.36190.70765.177.49336,949.50-22.97-11.48-31.53-16.5555.3461.28-32.47-17.701.06-4.430.5425---7.752.24-95.17--23.29--
REMSleep Holdings Inc203.73k-1.78m15.42m6.00--16.70--75.69-0.0012-0.00120.00010.00060.08921.6619.66---77.85-152.40-92.09-317.98-371.44---872.65-2,317.523.18-353.980.00---36.48--12.13--28.26--
PAVmed Inc2.45m-66.27m15.68m107.00------6.40-9.24-9.240.3392-6.280.0563--62.8722,915.89-182.01-154.56---1,152.82-161.87---3,232.63-8,764.890.447-10.582.19--550.40--25.76--55.51--
Orgenesis Inc530.00k-55.36m17.17m146.00------32.40-1.97-1.970.0184-0.65830.0181.230.02923,630.14-123.09---313.24---1,080.19---12,248.68--0.2464-16.1816.82---98.53-50.94-271.82---17.71--
QT Imaging Holdings Inc0.00-4.02m17.33m----0.7974-----0.3999-0.39990.001.010.00-------12.32---16.60--------------0.3042-------45.07------
Dalrada Financial Corporation31.32m-22.48m17.37m0.00------0.5546-0.2547-0.25470.3552-0.03341.229.255.22---90.33-80.63-513.68--25.0139.23-74.24-63.940.6296-25.241.61--54.35---43.94------
Agape ATP Corp1.43m-2.10m17.55m21.00--4.02--12.26-0.0276-0.02760.01890.05680.335310.5028.0968,147.14-49.44---68.03--65.44---147.44--4.79--0.0179---22.92---24.61------
Meihua International Medical Tech Co Ltd96.70m6.75m17.56m626.002.510.11892.390.18160.27510.27514.085.800.589943.821.39154,478.504.06--4.74--35.55--6.88--5.6298.280.0489---0.6645---70.20------
Akili Inc1.68m-59.49m18.46m68.00--0.3145--11.00-0.761-0.7610.02150.7470.0149--9.8424,676.47-52.90---59.98--51.19---3,545.47-----27.180.1817--419.50---212.48------
Data as of Apr 30 2024. Currency figures normalised to STRATA Skin Sciences Inc's reporting currency: US Dollar USD

Institutional shareholders

31.89%Per cent of shares held by top holders
HolderShares% Held
22NW LPas of 31 Dec 20235.37m15.32%
Nantahala Capital Management LLCas of 31 Dec 20233.13m8.93%
Renaissance Technologies LLCas of 31 Dec 20231.07m3.05%
The Vanguard Group, Inc.as of 31 Dec 2023858.20k2.45%
Cannell Capital LLCas of 31 Dec 2023275.81k0.79%
Geode Capital Management LLCas of 31 Dec 2023110.62k0.32%
Creative Planning LLCas of 31 Dec 2023100.16k0.29%
Perritt Capital Management, Inc.as of 31 Dec 2023100.00k0.29%
BlackRock Fund Advisorsas of 31 Dec 202393.54k0.27%
MGO One Seven LLCas of 31 Dec 202371.42k0.20%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.